Greenberg Traurig Shareholder A.J. Tibbetts will be a panelist during MassBio's "AI and Machine Learning: Parsing hype from real successes in the life sciences" on Monday, September 11 from 8:00 - 10:00 a.m. EST. This panel discussion will put artificial intelligence and machine learning under the microscope to cut through the hype and elevate the conversation on recent successes and the potential for advances.
Key topics discussed will include:
- What area(s) will we see the most progress (i.e. data analytics; discovery; personalized medicine; diagnostics) in the short term?
- What patient outcomes will be impacted and how soon?
- In practical terms, how can biotechs of various sizes accelerate the use of AI / machine learning in their research and business systems?
- Can AI / machine learning be used as a tool to achieve health equity or is it destined to be yet another breakthrough with limits on access and availability?